MicroRNA-30e targets BNIP3L to protect against aldosterone-induced podocyte apoptosis and mitochondrial dysfunction

Yan Guo1,2, Xu Deng1,2, Shuang Chen1,2

  • 1Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China; and.

Insights

MicroRNA-30e (miR-30e) protects kidney podocytes from aldosterone-induced injury. It prevents mitochondrial dysfunction and apoptosis by targeting the BNIP3L gene, offering a potential therapeutic target for kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs regulate podocyte homeostasis and injury.
  • MicroRNA-30a shows protective effects, but other family members' roles are unknown.
  • Aldosterone induces podocyte injury, involving mitochondrial dysfunction.

Purpose of the Study:

  • Investigate miR-30e's role in aldosterone-induced podocyte injury.
  • Elucidate the underlying molecular mechanism involving BNIP3L.

Main Methods:

  • Aldosterone treatment of podocytes.
  • Overexpression and silencing of miR-30e and BNIP3L.
  • Assessment of apoptosis and mitochondrial dysfunction.
  • Gene target analysis using luciferase assay.

Main Results:

  • Aldosterone reduced miR-30e levels in a dose- and time-dependent manner.
  • miR-30e overexpression attenuated aldosterone-induced apoptosis and mitochondrial dysfunction.
  • miR-30e directly targets BNIP3L, which mediates aldosterone-induced podocyte injury.

Conclusions:

  • miR-30e protects podocytes from aldosterone-induced injury.
  • This protection is achieved by targeting BNIP3L and ameliorating mitochondrial dysfunction.
  • miR-30e represents a potential therapeutic target for kidney diseases involving aldosterone-induced podocyte damage.

Related Concept Videos